Juvise Pharmaceuticals

filter Active Ingredients

All (2)

01 BISMUTH SUBCITRATE POTASSIUM; METRONIDAZOLE; TETRACYCLINE HYDROCHLORIDE (1)

02 Betahistine Dimesilate (1)

filter Applicant

All (2)

01 Juvise Pharmaceuticals (1)

02 LABS JUVISE (1)

filter Dosage Form

All (2)

01 CAPSULE;ORAL (1)

02 Capsule (1)

filter Dosage

All (2)

01 12MG (1)

02 140MG;125MG;125MG (1)

filter Country

All (2)

01 France (1)

02 USA (1)

Juvise Pharmaceuticals's list of EU CTD Dossiers, Marketing Authorizations, In, Out Licensing Opportunities & Finished Dosage Formulations aggregated by PharmaCompass

About

Contact Details

EVENTS

Webinars & Exhibitions

PRESENTATION(s)

Corporate Presentation

VIDEO(s)

DIGITAL CONTENT

7 News

DEVELOPMENTS

3 Drug(s) in Development

DOSSIERs // Finished Dosage Forms

2 Dossiers

1 FDA Orange Book

1 Listed Dossiers

Juvise Pharmaceuticals

Betahistine Dimesilate

Capsule

12MG

EXTOVYL

France

BISMUTH SUBCITRATE POTASSIUM; METRONIDAZOLE; TETRACYCLINE HYDROCHLORIDE

CAPSULE;ORAL

140MG;125MG;125MG

PYLERA

USA

50786

2006-09-28

RX